Results 181 to 190 of about 245,064 (314)

Design and Evaluation of a Faculty Development Workshop Series on Integrating Generative Artificial Intelligence in Medical Education: Mixed Methods Pilot Study. [PDF]

JMIR Med Educ
Anand R, Bowers N, Manyama MF.
europepmc   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

Analysis of Research Trends and Output Effectiveness in the Medical Field Based on the National Natural Science Foundation of China. [PDF]

Health Care Sci
Jin H, Hui H, Xinjie B, Hua B.
europepmc   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Small Business Innovation Research : Program Solicitation (Closing Date : May 1, 1998)

The Small Business Innovation Research (SBIR) Program is the primary vehicle through which the federal government funds research and development (R&D) projects at small technology companies.
John A. Volpe National Transportation Systems Center (U.S.)
core  

Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD). [PDF]

Stroke Vasc Neurol
Wang Y, Xie X, Xu J, Lei P, Wang K, Zhang J, Yu J, Cui M, Dong Q.   +8 more
europepmc   +1 more source

Hydrostatic pressure activates HIF‐1α via β‐catenin to promote stemness in breast cancer cells

FEBS Open Bio, EarlyView.
To mimic the elevated intestinal fluid pressure in breast cancers, we loaded human breast cancer cells (MCF‐7, MDA‐MB‐453, and BT‐474) to 50 mmHg hydrostatic pressure. Hydrostatic pressure exposure upregulated HIF‐1α and induced stemness in MCF‐7 and BT‐474 cells.
Da Zhai, Yong Xu, Jingjing Ma, Ratchanee Duangrat, Chen Yan, Jingyan Liang, Hua Wei, Bin Jiang, Tao‐Sheng Li   +8 more
wiley   +1 more source

Interfaces between communication, education and health: a scoping review protocol. [PDF]

BMJ Open
Araújo do Nascimento Batista N, Henriques S, Lacerda J, de Pinho Dias A, Muñoz Gallego A, Correia Neves Abreu D, Aires Clemente H, Emiliano Bidarra de Almeida JM, Sampaio de Araújo K, Dantas Coutinho K, Sanjuán Núñez L, Romão MH, Cunha Dantas Freire MDG, Nogueira Tavares ME, Santos Reis MK, Lorite García N, Valentim R.   +16 more
europepmc   +1 more source

NSF Continues Appropriate Technology Research Program [PDF]

Anthropology News, 1980
openaire   +1 more source

Emerging insights into CC and CXC chemokines and their receptors in Mycobacterium tuberculosis infection

FEBS Open Bio, EarlyView.
The dual roles of CC and CXC chemokines in distinguishing active, latent, and subclinical tuberculosis were reviewed, along with an evaluation of their potential as diagnostic biomarkers and therapeutic targets to advance precision medicine in tuberculosis management. The graphical abstract was generated with AI assistance (Gemini 3.0).
Xuying Yin, Dangsheng Xiao, Jiezuan Yang
wiley   +1 more source